References
- Abbasi S, Maleha F, Shobaki M. Acute lymphoblastic leukemia experience: epidemiology and outcome of two different regimens. Mediterr J Hematol Infect Dis. 2013 Apr 10;5(1):e2013024.
- Katz AJ, Chia VM, Schoonen WM, Kelsh MA. Acute lymphoblastic leukemia: an assessment of international incidence, survival, and disease burden. Cancer Causes Control. 2015 Nov;26(11):1627–42.
- van Santen HM, Thonissen NM, de Kraker J, Vulsma T. Changes in thyroid hormone state in children receiving chemotherapy. Clin Endocrinol (Oxf). 2005 Feb;62(2):250–7.
- Yu H, Han J, Wu X, Qiu Y, Yu H, Xu J, Hao J, Peng Y, Jin R, Zhou F. Hypothyroidism in induction chemotherapy of children with acute lymphoblastic leukaemia: A single-centre study. Int J Cancer. 2023 Aug 1;153(3):669–680.
- Lebbink CA, van den Bos C, Dierselhuis MP, Fiocco M, Verrijn Stuart AA, Lentjes EGWM, Plasschaert SLA, Tissing WJE, van Santen HM. Thyroid Profile in the First Three Months after Starting Treatment in Children with Newly Diagnosed Cancer. Cancers (Basel). 2023 Feb 27;15(5):1500.
- van den Berghe, G. Euthyroid sick syndrome. Curr. Opin. Anesthesiol. 2000, 13, 89–91.
- van Iersel L, Xu J, Potter BS, Conklin HM, Zhang H, Chemaitilly W, van Santen HM, Merchant TE. Clinical Importance of Free Thyroxine Concentration Decline After Radiotherapy for Pediatric and Adolescent Brain Tumors. J Clin Endocrinol Metab. 2019 Nov 1;104(11):4998–5007.
- Xiu S, Mu Z, Zhao L, Sun L. Low free triiodothyronine levels are associated with risk of frailty in older adults with type 2 diabetes mellitus. Exp Gerontol. 2020 Sep;138:111013.
- Gökbuget N, Ihrig K, Stadler M, Stelljes M, Elmaagacli A, Starck M, Raffel S, Stoltefuss A, Viardot A, Kreuzer KA, Heidenreich D, Renzelmann A, Wäsch R, Topp MS, Ritter B, Reimer P, Beck J, Westermann J, Wendelin K, Alakel N, Hanoun M, Serve H, Hoelzer D. General condition and comorbidity of long-term survivors of adult acute lymphoblastic leukemia. Haematologica. 2023 Jul 1;108(7):1758–1767.
- Gao Y, Zhou JF, Mao JY, Jiang L, Li XP. Identification of the Thyrotropin-Releasing Hormone (TRH) as a Novel Biomarker in the Prognosis for Acute Myeloid Leukemia. Biomolecules. 2022 Sep 23;12(10):1359.
- Aryee NA, Adu-Bonsaffoh K, Arko-Boham B, Quaye O, Asazu H, Tagoe E. Thyroid hormone profile in preeclampsia patients: a case control study. Gynecol Endocrinol. 2023 Dec;39(1):2186136.
- Beck-Peccoz P, Rodari G, Giavoli C, Lania A. Central hypothyroidism - a neglected thyroid disorder. Nat Rev Endocrinol. 2017 Oct;13(10):588–598.
- Ganesan K, Anastasopoulou C, Wadud K. Euthyroid Sick Syndrome. 2022 Dec 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–.
- Nygaard B. Hyperthyroidism (primary). BMJ Clin Evid. 2010 Jul 19;2010:0611.
- Rotz SJ, Wei W, Thomas SM, Hanna R. Distance to treatment center is associated with survival in children and young adults with acute lymphoblastic leukemia. Cancer. 2020 Dec 15;126(24):5319–5327.
- Shimazaki S, Kazukawa I, Mori K, Kihara M, Minagawa M. Factors predicting endocrine late effects in childhood cancer survivors from a Japanese hospital. Endocr J. 2020 Feb 28;67(2):131–140
- Malakoutikhah Z, Ashrafi F, Derakhshandeh A. Prognostic Factors and Outcome of Patients with Adult Acute Lymphoblastic Leukemia Treated with the Hyper-CVAD Regimen: A Retrospective Study. Adv Hematol. 2023 Nov 9;2023:5593635.
- Verhaak RG, Wouters BJ, Erpelinck CA, Abbas S, Beverloo HB, Lugthart S, Löwenberg B, Delwel R, Valk PJ. Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling. Haematologica. 2009 Jan;94(1):131–4.
- Pasqualini T, McCalla J, Berg S, Poplack DG, Rose SR, Nisula BC and Fernando Cassorla F. Subtle primary hypothyroidism in patients treated for acute lymphoblastic leukemia. Acta Endocrinologica (Copenh) 1991, 24: 375–380
- Howard SC, Pui CH: Endocrine complications in pediatric patients with acute lymphoblastic leukemia. Blood Reviews (2002) 16, 225–243
- Karakaya P, Yılmaz S, Tüfekçi Ö, Kır M, Böber E, İrken G, Ören H. Endocrinological and Cardiological Late Effects Among Survivors of Childhood Acute Lymphoblastic Leukemia. Turk J Hematol 2013;30:290–299. DOI: 10.4274/Tjh.2012.0094
- Kranjčec I, Matijašić N, Oletić L, Grizelj A, Štromar L. Does transitory steroid-induced central hypothyroidism in children treated for haematological malignancies warrant clinical intervention? Pediatr Endocrinol Diabetes Metab. 2022;28(4):245–249.
- Rose SR, Schreiber RE, Kearney NS, Lustig RH, Danish RK, Burghen GA, Hudson MM. Hypothalamic dysfunction after chemotherapy. J Pediatr Endocrinol Metab. 2004 Jan;17(1):55–66.
- Baronio F, Battisti L, Radetti G. Central hypothyroidism following chemotherapy for acute lymphoblastic leukemia. J Pediatr Endocr Met 2011; 24: 903–906.
- Haugen BR. Drugs that suppress TSH or cause central hypothyroidism. Pract Res Clin Endocrinol Metab 2009; 23: 793–800. doi:10.1016/j.beem.2009.08.003.
- Gupta V, Lee M. Central hypothyroidism. Indian J Endocrinol Metab 2011; 15 (Suppl2): S99–S106.